Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The BioCollective
Denver, Colorado, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
The BioCollective has launched commercial products (e.g., Sugar Shift) that have demonstrated reduction in fasting blood glucose and modulation of gut metabolites; the company is also active in early-stage research and biomarker development for neurodegenerative and metabolic diseases.[1][3][4]
- Therapeutic areas
- EndocrinologyNeurologyGastroenterologyMetabolic Disorders
- Modalities
- Live biotherapeutic product therapyMicrobial therapyProbioticSmall molecule
- Industry
- Biotech
02
Partnerships
Zymo ResearchJanssen Mosaic ChallengeNational Institute of Standards and TechnologyArdigen
Beyond the preview
Go deeper on The BioCollective.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on The BioCollective.